Form 4: Bicycle Therapeutics CFO Alethia Young Sells Shares to Cover Tax Obligations
SEC Form 4
Alethia Young, CFO of Bicycle Therapeutics PLC, sold 215 ordinary shares on April 2, 2025, to cover statutory tax withholding obligations related to the vesting and settlement of restricted stock units.
Summary
- On April 2, 2025, Alethia Young, the Chief Financial Officer of Bicycle Therapeutics PLC, sold 215 ordinary shares of the company.
- The sale was executed at a weighted average price of $8.02 per share, with individual transactions ranging from $8.00 to $8.12.
- This transaction was conducted to cover statutory tax withholding obligations associated with the vesting and settlement of restricted stock units, as mandated by Young's award agreement.
- Following the transaction, Young still beneficially owns 45,390 ordinary shares of Bicycle Therapeutics PLC.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction (sale of shares to cover taxes) and doesn't suggest any underlying issues with the company. It's a neutral event.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally not indicative of a negative outlook on the company's future.
Key Dates
| Date | Description |
|---|---|
| 04/02/2025 | Date of the share sale transaction. |
| 04/04/2025 | Date of signature on the Form 4 filing. |
Keywords
Bicycle Therapeutics PLC, Alethia Young, Chief Financial Officer, BCYC, Share Sale, Tax Withholding, Restricted Stock Units, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.